Showing results (1-10 of 187) with videos related to
Sort By:
Pageof 19
Oncology (Williston Park, N.Y.)|August 31, 2002
What is the optimal therapy for childhood AML?David M Loeb, Robert J ArceciPediatric Blood & Cancer|December 17, 2004
Significant responses to platinum-based chemotherapy in renal medullary carcinomaJohn J Strouse, Melissa Spevak, A Kyle Mack, et al.Current Opinion in Hematology|June 10, 2008
When T cells and macrophages do not talk: the hemophagocytic syndromesRobert J ArceciCurrent Opinion in Hematology|June 4, 2002
Progress and controversies in the treatment of pediatric acute myelogenous leukemiaRobert J ArceciAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Biological and therapeutic implications of the BRAF pathway in histiocytic disordersRobert J ArceciThe Oncologist|April 5, 2007
Prognostic factors and risk-based therapy in pediatric acute myeloid leukemiaSoheil Meshinchi, Robert J ArceciFrontiers in Cell and Developmental Biology|April 28, 2015
Targeting cell cycle regulators in hematologic malignanciesEiman Aleem, Robert J ArceciHematology/Oncology Clinics of North America|October 14, 2015
Strategies for the Prevention of Central Nervous System Complications in Patients with Langerhans Cell Histiocytosis: The Problem of Neurodegenerative SyndromeShinsaku Imashuku, Robert J ArceciFrontiers in Cell and Developmental Biology|March 26, 2015
Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell lineJoseph B Moore, David M Loeb, Kyung U Hong, et al.Pediatric Clinics of North America|February 13, 2003
Emerging cancer-targeted therapiesRobert J Arceci, Timothy P CripePageof 19